Your browser doesn't support javascript.
loading
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
Whelan, J S; Bielack, S S; Marina, N; Smeland, S; Jovic, G; Hook, J M; Krailo, M; Anninga, J; Butterfass-Bahloul, T; Böhling, T; Calaminus, G; Capra, M; Deffenbaugh, C; Dhooge, C; Eriksson, M; Flanagan, A M; Gelderblom, H; Goorin, A; Gorlick, R; Gosheger, G; Grimer, R J; Hall, K S; Helmke, K; Hogendoorn, P C W; Jundt, G; Kager, L; Kuehne, T; Lau, C C; Letson, G D; Meyer, J; Meyers, P A; Morris, C; Mottl, H; Nadel, H; Nagarajan, R; Randall, R L; Schomberg, P; Schwarz, R; Teot, L A; Sydes, M R; Bernstein, M.
Afiliação
  • Whelan JS; Department of Oncology, University College Hospital, London, UK.
  • Bielack SS; Cooperative Osteosarcoma Study Group (COSS), Klinikum Stuttgart - Olgahospital, Stuttgart, Germany.
  • Marina N; Stanford University Medical Center, Pediatric Hematology/Oncology, Palo Alto, USA.
  • Smeland S; Division of Cancer, Surgery and Transplantation, and Scandinavian Sarcoma Group, Oslo University Hospital, Oslo Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
  • Jovic G; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Hook JM; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Krailo M; Children's Oncology Group, Arcadia, USA.
  • Anninga J; Department of Pediatrics and Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Butterfass-Bahloul T; Center for Clinical Trials, University Hospital Münster, Münster, Germany.
  • Böhling T; University of Helsinki and HUSLAB, Helsinki, Finland.
  • Calaminus G; University Hospital of Muenster, Muenster, Germany.
  • Capra M; Our Lady's Children's Hospital, Dublin, Ireland.
  • Deffenbaugh C; Lucile Salter Packard Childrens Hospital Stanford, Palo Alto, USA.
  • Dhooge C; University Hospital Ghent, Gent, Belgium.
  • Eriksson M; Skane University Hospital, Lund University, Lund, Sweden.
  • Flanagan AM; Royal National Orthopaedic Hospital, Stanmore Cancer Institute, University College London, London, UK.
  • Gelderblom H; Department of Pediatrics and Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Goorin A; Dana-Farber Cancer Institute, Boston.
  • Gorlick R; Section of Pediatric Hematology/Oncology, Montefiore Medical Center, Bronx, USA.
  • Gosheger G; Department of General Orthopedics and Tumor Orthopedics, University Hospital Muenster, Muenster, Germany.
  • Grimer RJ; Royal Orthopaedic Hospital, Birmingham, UK.
  • Hall KS; Department of Oncology, Oslo University Hospital, Norwegian Radium Hospital, Scandinavian Sarcoma Group, Oslo, Norway.
  • Helmke K; Department of Pediatric Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hogendoorn PC; Department of Pediatrics and Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Jundt G; Bone Tumor Reference Center at the Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Kager L; St Anna Children's Hospital, Vienna, Austria.
  • Kuehne T; University Children's Hospital Basel, Basel, Switzerland.
  • Lau CC; Texas Children's Cancer Centre, Baylor College of Medicine, Houston.
  • Letson GD; H. Lee Moffit Cancer Centre & Research Institute, Tampa.
  • Meyer J; Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia.
  • Meyers PA; Memorial Sloan-Kettering Cancer Center, New?York.
  • Morris C; Memorial Sloan-Kettering Cancer Center, New?York Orthopedic Surgery, Johns Hopkins, Baltimore, USA.
  • Mottl H; Department of Pediatric Hematology Oncology, University Hospital, Prague, Czech Republic.
  • Nadel H; British Columbia Children's Hospital, University of British Columbia, Vancouver, Canada.
  • Nagarajan R; Cincinnati Children's Hospital Medical Center, Cincinnati.
  • Randall RL; Primary Children's Hospital and Huntsman Cancer Institute, University of Utah, Salt Lake City.
  • Schomberg P; Mayo Clinic, Rochester, USA.
  • Schwarz R; Department of Radiation Oncology, Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Teot LA; Department of Pathology, Boston Children's Hospital, Boston, USA.
  • Sydes MR; Medical Research Council Clinical Trials Unit at University College London, London, UK m.sydes@ucl.ac.uk.
  • Bernstein M; IWK Health Center, Dalhousie University, Halifax, Canada.
Ann Oncol ; 26(2): 407-14, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25421877
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido